Dopamine D3 receptor antisense administration reduces basalc-fos and NGFI-B mRNA levels in the rat forebrain
- 23 February 1999
- Vol. 32 (1) , 51-57
- https://doi.org/10.1002/(sici)1098-2396(199904)32:1<51::aid-syn7>3.0.co;2-e
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZIEuropean Journal of Pharmacology, 1998
- Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotidesNeuroReport, 1998
- Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neurolepticsEuropean Journal of Pharmacology, 1996
- Antipsychotics with inverse agonist activity at the dopamine D3 receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proceedings of the National Academy of Sciences, 1996
- Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptorsNature, 1995
- Lack of Discrimination by Agonists for D2 and D3 Dopamine ReceptorsNeuropsychopharmacology, 1995
- Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus AccumbensEuropean Journal of Neuroscience, 1994
- Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNABrain Research, 1991
- Mesocorticolimbic dopaminergic network: functional and regulatory rolesPhysiological Reviews, 1991